GENINCODE PLC — Investor Relations & Filings
GENINCODE PLC specializes in the genetic risk assessment and prediction of cardiovascular disease (CVD). The company develops and commercializes clinical genetic tests that combine genomic data with clinical algorithms and artificial intelligence (AI). These advanced risk assessment tools provide physicians with a predictive analysis of a patient's health, enabling personalized prevention and treatment strategies for CVD. The company's technology is founded on over 15 years of research and development in cardiovascular genomics, aiming to improve patient outcomes by identifying at-risk individuals before the onset of disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2026-05-08 | English | |
| Grant of Share Options & PDMR Dealings | 2026-05-07 | English | |
| Holding(s) in Company | 2026-02-26 | English | |
| Holding(s) in Company | 2026-02-24 | English | |
| Holding(s) in Company | 2026-02-12 | English | |
| Holding(s) in Company | 2026-02-12 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 44302284 | Holding(s) in Company | 2026-05-08 | English | ||
| 42453279 | Grant of Share Options & PDMR Dealings | 2026-05-07 | English | ||
| 32843679 | Holding(s) in Company | 2026-02-26 | English | ||
| 34563216 | Holding(s) in Company | 2026-02-24 | English | ||
| 19467055 | Holding(s) in Company | 2026-02-12 | English | ||
| 19466908 | Holding(s) in Company | 2026-02-12 | English | ||
| 19466858 | Holding(s) in Company | 2026-02-12 | English | ||
| 18247395 | Result of GM, Director Shareholdings and TVR | 2026-02-09 | English | ||
| 14783432 | Additional Subscription | 2026-02-06 | English | ||
| 13343227 | Result of Retail Offer | 2026-01-26 | English | ||
| 13199807 | Result of Placing and Subscription | 2026-01-22 | English | ||
| 13159849 | Retail Offer | 2026-01-21 | English | ||
| 13159846 | Placing and Subscription | 2026-01-21 | English | ||
|
2025
2 filings
| |||||
| 10225432 | Collaboration with Sohin Genetics | 2025-12-17 | English | ||
| 9627671 | Holding(s) in Company | 2025-12-08 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for GENINCODE PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
RACURA ONCOLOGY LTD
Clinical-stage developer of precision oncology therapeutics…
|
RAC | AU | Professional, scientific and te… |
|
RADIOPHARM THERANOSTICS LIMITED
Clinical-stage company developing radiopharmaceutical produ…
|
RAD | AU | Professional, scientific and te… |
|
Radiopharm Theranostics Ltd
Clinical-stage company developing radiopharmaceuticals for …
|
RADX | US | Professional, scientific and te… |
|
Rafael Holdings, Inc.
Invests in and develops therapies for cancer and rare genet…
|
RFL | US | Professional, scientific and te… |
|
Rain Enhancement Technologies Holdco, Inc.
Develops ionization-based weather modification technology f…
|
RAIN | US | Professional, scientific and te… |
|
Rakovina Therapeutics Inc.
Biopharma developing targeted cancer treatments using AI to…
|
RKV | CA | Professional, scientific and te… |
|
Rallybio Corp
A clinical-stage biotech company developing therapies for s…
|
RLYB | US | Professional, scientific and te… |
|
RaQualia Pharma Inc.
Develops and out-licenses innovative small molecule drug co…
|
4579 | JP | Professional, scientific and te… |
|
RECURSION PHARMACEUTICALS, INC.
A clinical-stage company applying AI and machine learning t…
|
RXRX | US | Professional, scientific and te… |
|
RELMADA THERAPEUTICS, INC.
Clinical-stage biotech developing therapies for bladder can…
|
RLMD | US | Professional, scientific and te… |
GENINCODE PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7669/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7669 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7669 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7669 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7669}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GENINCODE PLC (id: 7669)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.